Thursday, 23 October 2014
Last updated 13 hours ago
Jun 14 2011 | 8:28am ET
Stamford-based MKM Partners has hired Jon LeCroy, M.D., as managing director in its equity research department covering biotechnology and specialty pharmaceuticals companies. The hire marks the beginning of the company’s expansion into the healthcare sector.
LeCroy has covered the same sector at Goldman Sachs, Natixis Bleichroeder and, most recently, at Hapoalim Securities USA.
"Our move into the healthcare vertical expands MKM's research footprint," said MKM Partners CEO Richard R. Castellano. "Jon's in-depth and actionable research—and his stockpicking prowess—will make him a key resource for MKM's existing institutional equity client base and enable us to service new clients focused on investment opportunities in healthcare."
MKM Partners is an institutional equity research, sales and trading firm.
Sep 22 2014 | 4:15pm ET
"I tell people that everybody likes good news and so if you have good performance that’s wonderful,” explains Mike McKitish of Peddie School's endowment, “but it’s the people that want to talk about the bad news or where they drifted and how they came back and how they stayed to their discipline…” that he wants to hear from. Read more…
Most traders agree that proper risk management is the key to successful trading. However, many traders depend on the deeply flawed measure of standard deviation as a benchmark of risk. Here we put it ...